GUGGENHEIM CAPITAL LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$3,157,000
-19.2%
253,807
-11.1%
0.01%
-25.0%
Q3 2016$3,909,000
+50.1%
285,532
-19.0%
0.01%
+50.0%
Q2 2016$2,605,000
+7.7%
352,467
-6.9%
0.01%0.0%
Q1 2016$2,419,000
-35.1%
378,568
-36.5%
0.01%
-27.3%
Q4 2015$3,728,000
-15.3%
596,448
-20.9%
0.01%
-21.4%
Q3 2015$4,401,000
-37.1%
753,679
-10.9%
0.01%
-17.6%
Q2 2015$6,993,000
+19.1%
845,615
+18.7%
0.02%
+21.4%
Q1 2015$5,870,000
+49.5%
712,320
+24.7%
0.01%
+40.0%
Q4 2014$3,926,000
+30.0%
571,443
+2.2%
0.01%
+42.9%
Q3 2014$3,021,000
-8.4%
559,392
+8.1%
0.01%
-12.5%
Q2 2014$3,297,000
-39.6%
517,570
-23.6%
0.01%
-50.0%
Q1 2014$5,459,000
+44.0%
677,369
+21.8%
0.02%
+33.3%
Q4 2013$3,792,000
-43.0%
556,030
+53.8%
0.01%
-50.0%
Q3 2013$6,651,000
+12.9%
361,471
+7.3%
0.02%
-4.0%
Q2 2013$5,890,000336,7670.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,000,000$96,720,00033.30%
Opaleye Management Inc. 1,670,000$13,460,0009.94%
Slate Path Capital LP 6,620,000$53,357,0004.04%
Granite Point Capital Management, L.P. 648,000$5,223,0003.74%
Palo Alto Investors LP 6,917,248$55,754,0002.30%
Camber Capital Management LP 3,000,000$24,180,0001.90%
Geduld E E 277,600$2,237,0001.21%
Elk Creek Partners, LLC 290,886$2,345,0001.01%
SELZ CAPITAL LLC 400,000$3,224,0000.81%
GENERAL AMERICAN INVESTORS CO INC 1,200,000$9,672,0000.81%
View complete list of ARIAD PHARMACEUTICALS INC shareholders